Cargando…
Focal treatment of spasticity using botulinum toxin A in cerebral palsy cases of GMFCS level V: evaluation of adverse effects()()
OBJECTIVE: To report on the experience of injections of botulinum toxin A (BTA) in a series of patients with cerebral palsy of Gross Motor Function Classification System (GMFCS) level V. METHODS: This was a retrospective case series study on 33 patients with cerebral palsy of GMFCS level V who recei...
Autores principales: | Tedesco, Ana Paula, Martins, Juliana Saccol, Nicolini-Panisson, Renata D’Agostini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511629/ https://www.ncbi.nlm.nih.gov/pubmed/26229827 http://dx.doi.org/10.1016/j.rboe.2014.04.022 |
Ejemplares similares
-
SHUEE on the evaluation of upper limb in cerebral palsy
por: Tedesco, Ana Paula, et al.
Publicado: (2015) -
SELECTIVE DORSAL RHIZOTOMY IN CEREBRAL PALSY: SELECTION CRITERIA AND
POSTOPERATIVE PHYSICAL THERAPY PROTOCOLS
por: Nicolini-Panisson, Renata D’Agostini, et al.
Publicado: (2018) -
CORRELATION BETWEEN VISUAL GAIT ANALYSIS AND FUNCTIONAL ASPECTS IN CEREBRAL PALSY
por: FOLLE, MAIRA RECH, et al.
Publicado: (2016) -
Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016) -
A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use
por: Valentine, Jane, et al.
Publicado: (2020)